Compare BNTC & SUJA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BNTC | SUJA |
|---|---|---|
| Founded | 1995 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 454.2M | 426.8M |
| IPO Year | 2020 | 2026 |
| Metric | BNTC | SUJA |
|---|---|---|
| Price | $12.32 | $8.89 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $27.67 | N/A |
| AVG Volume (30 Days) | 115.3K | ★ 710.1K |
| Earning Date | 05-14-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 80.94 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.85 | $5.59 |
| 52 Week High | $16.76 | $11.93 |
| Indicator | BNTC | SUJA |
|---|---|---|
| Relative Strength Index (RSI) | 44.44 | 48.87 |
| Support Level | $11.39 | $8.80 |
| Resistance Level | $13.51 | $10.94 |
| Average True Range (ATR) | 0.61 | 0.68 |
| MACD | -0.07 | -0.04 |
| Stochastic Oscillator | 28.03 | 8.59 |
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.